U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C11H16O
Molecular Weight 164.2441
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of FENIPENTOL

SMILES

CCCCC(O)C1=CC=CC=C1

InChI

InChIKey=OVGORFFCBUIFIA-UHFFFAOYSA-N
InChI=1S/C11H16O/c1-2-3-9-11(12)10-7-5-4-6-8-10/h4-8,11-12H,2-3,9H2,1H3

HIDE SMILES / InChI

Molecular Formula C11H16O
Molecular Weight 164.2441
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Description

Fenipentol is a choleretic agent indicated for the treatment of chronic liver disease and bile duct disease. The drug is sold without prescription.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
FEBICHOL
Primary
FEBICHOL
PubMed

PubMed

TitleDatePubMed
[Contact sensitization to pharmaceutic aids in dermatologic cosmetic and external use preparations].
2004 May
Synthesis and antioxidant properties of some indole ethylamine derivatives as melatonin analogs.
2005 Sep
Running speed in mammals increases with muscle n-6 polyunsaturated fatty acid content.
2006 Dec 20
Dietary exposure of children and teenagers to benzoates, sulphites, butylhydroxyanisol (BHA) and butylhydroxytoluen (BHT) in Beirut (Lebanon).
2007 Feb
Improved and efficient synthesis of chiral N,P-ligands via cyclic sulfamidates for asymmetric addition of butyllithium to benzaldehyde.
2007 Sep 13
Monocytes of patients with familial hypercholesterolemia show alterations in cholesterol metabolism.
2008 Nov 28
Hypercholesterolemia in rats impairs the cholinergic system and leads to memory deficits.
2010 Dec
Contribution of dietary intakes of antioxidants to homocysteine-induced low density lipoprotein (LDL) oxidation in atherosclerotic patients.
2010 Jul
Patents

Sample Use Guides

In Vivo Use Guide
Standard dosage for adults and youths over 15 years of age is 2 capsules (each capsule of contains 100 mg of active ingredient fenipentol) three times a day (always immediately before meals).
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Tue Oct 22 05:37:08 UTC 2019
Edited
by admin
on Tue Oct 22 05:37:08 UTC 2019
Record UNII
X3FZE77O60
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
FENIPENTOL
INN   JAN   MART.   MI   WHO-DD  
INN  
Official Name English
BENZYL ALCOHOL, .ALPHA.-BUTYL-
Systematic Name English
PHENYLBUTYLCARBINOL
Systematic Name English
FENIPENTOL [JAN]
Common Name English
FENIPENTOL [MART.]
Common Name English
FENIPENTOL [MI]
Common Name English
1-PHENYL-1-HYDROXY-N-PENTANE
Common Name English
(+/-)-.ALPHA.-BUTYLBENZYL ALCOHOL
Systematic Name English
PH-BC
Code English
1-PHENYL-1-HYDROXYPENTANE
Systematic Name English
FENIPENTOL [WHO-DD]
Common Name English
FENIPENTOL [INN]
Common Name English
(+/-)-1-PHENYL-1-PENTANOL
Systematic Name English
PC-1
Code English
NSC-8478
Code English
PANCORAL
Brand Name English
1-PENTANOL, 1-PHENYL-
Systematic Name English
.ALPHA.-BUTYLBENZYL ALCOHOL
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C66913
Created by admin on Tue Oct 22 05:37:08 UTC 2019 , Edited by admin on Tue Oct 22 05:37:08 UTC 2019
Code System Code Type Description
CAS
583-03-9
Created by admin on Tue Oct 22 05:37:08 UTC 2019 , Edited by admin on Tue Oct 22 05:37:08 UTC 2019
PRIMARY
ChEMBL
CHEMBL2104321
Created by admin on Tue Oct 22 05:37:08 UTC 2019 , Edited by admin on Tue Oct 22 05:37:08 UTC 2019
PRIMARY
MESH
C013992
Created by admin on Tue Oct 22 05:37:08 UTC 2019 , Edited by admin on Tue Oct 22 05:37:08 UTC 2019
PRIMARY
NCI_THESAURUS
C65652
Created by admin on Tue Oct 22 05:37:08 UTC 2019 , Edited by admin on Tue Oct 22 05:37:08 UTC 2019
PRIMARY
CAS
21632-19-9
Created by admin on Tue Oct 22 05:37:08 UTC 2019 , Edited by admin on Tue Oct 22 05:37:08 UTC 2019
SUPERSEDED
PUBCHEM
3338
Created by admin on Tue Oct 22 05:37:08 UTC 2019 , Edited by admin on Tue Oct 22 05:37:08 UTC 2019
PRIMARY
CAS
136264-41-0
Created by admin on Tue Oct 22 05:37:08 UTC 2019 , Edited by admin on Tue Oct 22 05:37:08 UTC 2019
SUPERSEDED
EVMPD
SUB07567MIG
Created by admin on Tue Oct 22 05:37:08 UTC 2019 , Edited by admin on Tue Oct 22 05:37:08 UTC 2019
PRIMARY
INN
3413
Created by admin on Tue Oct 22 05:37:08 UTC 2019 , Edited by admin on Tue Oct 22 05:37:08 UTC 2019
PRIMARY
ECHA (EC/EINECS)
209-493-9
Created by admin on Tue Oct 22 05:37:08 UTC 2019 , Edited by admin on Tue Oct 22 05:37:08 UTC 2019
PRIMARY
RXCUI
24846
Created by admin on Tue Oct 22 05:37:08 UTC 2019 , Edited by admin on Tue Oct 22 05:37:08 UTC 2019
PRIMARY RxNorm
EPA CompTox
583-03-9
Created by admin on Tue Oct 22 05:37:08 UTC 2019 , Edited by admin on Tue Oct 22 05:37:08 UTC 2019
PRIMARY
MERCK INDEX
M5276
Created by admin on Tue Oct 22 05:37:08 UTC 2019 , Edited by admin on Tue Oct 22 05:37:08 UTC 2019
PRIMARY Merck Index
Related Record Type Details
ENANTIOMER -> RACEMATE
ENANTIOMER -> RACEMATE
Related Record Type Details
ACTIVE MOIETY